Literature DB >> 6475925

Systolic blood pressure and cancer mortality in an elderly population.

K T Khaw, E Barrett-Connor.   

Abstract

In a nine-year follow-up of a southern California community of 2,852 men and women aged 60-79 years, systolic blood pressure was a significant predictor of subsequent cancer mortality in men. This effect was independent of age, antihypertensive medication, smoking, obesity, and plasma cholesterol. Trends in women were similar but not statistically significant. Compared with those still alive, higher initial systolic blood pressure levels were apparent in those who died of colon cancer, stomach cancer, and all other cancers combined except for lung and prostate cancer. Possible mechanisms for this association and the implications of the data with regard to the benefits of measures to treat high blood pressure or lower population distribution of blood pressure are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6475925     DOI: 10.1093/oxfordjournals.aje.a113916

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  9 in total

1.  Expression of angiotensin II type 1 and type 2 receptor mRNAs in the gastric mucosa of Helicobacter pylori-infected Mongolian gerbils.

Authors:  Mitsushige Sugimoto; Tomoyuki Ohno; Yoshio Yamaoka
Journal:  J Gastroenterol       Date:  2011-07-13       Impact factor: 7.527

Review 2.  Role of renin-angiotensin system in gastric oncogenesis.

Authors:  Mitsushige Sugimoto; Yoshio Yamaoka; Naohito Shirai; Takahisa Furuta
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

3.  The 25 year estimated probability of death from some specific causes as a function of twelve risk factors in middle aged men.

Authors:  A Menotti; S Mariotti; S Seccareccia; S Giampaoli
Journal:  Eur J Epidemiol       Date:  1988-03       Impact factor: 8.082

4.  Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response.

Authors:  S Sud; C O'Callaghan; C Jonker; C Karapetis; T Price; N Tebbutt; J Shapiro; G Van Hazel; N Pavlakis; P Gibbs; M Jeffrey; L Siu; S Gill; R Wong; D Jonker; D Tu; R Goodwin
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

5.  Is serum selenium a risk factor for cancer?

Authors:  I Peleg; S Morris; C G Hames
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

6.  Hypertensive nephropathy and cancer: Is it the hypertension, the nephropathy, or both?

Authors:  Sabine Karam
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-05-24       Impact factor: 3.738

Review 7.  Antihypertensive therapy and cancer risk.

Authors:  D C Felmeden; G Y Lip
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

Review 8.  Critical review of cancer risk associated with angiotensin receptor blocker therapy.

Authors:  Grégoire Wuerzner; Michel Burnier; Bernard Waeber
Journal:  Vasc Health Risk Manag       Date:  2011-12-12

9.  Blood pressure and site-specific cancer mortality: evidence from the original Whitehall study.

Authors:  G D Batty; M J Shipley; M G Marmot; G Davey Smith
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.